This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Duke University, The University of North Carolina at Chapel Hill. Active years: 2021.
Company Filing History:
1 out of 2,075 
1 out of 1,325 
Years Active: 2021
Title: Julia Quintanilha: Innovator in Vascular Health
Introduction
Julia Quintanilha is a prominent inventor based in Chapel Hill, NC (US). She has made significant contributions to the field of vascular health through her innovative research and patent work. Her expertise lies in identifying risks associated with vascular endothelial growth factor (VEGF) pathway inhibitors, which are crucial in cancer treatment.
Latest Patents
Julia holds a patent titled "Methods of identifying risk of vascular endothelial growth factor (VEGF) pathway inhibitor-induced hypertension." This patent focuses on methods for identifying subjects at risk of developing toxicities, such as proteinuria and hypertension, due to the use of bevacizumab. The innovative approach involves measuring nucleic acid or gene mutations in samples obtained from the subjects, providing a valuable tool for personalized medicine.
Career Highlights
Throughout her career, Julia has worked with esteemed institutions, including the University of North Carolina at Chapel Hill and Duke University. Her work has been instrumental in advancing the understanding of the side effects associated with cancer therapies, particularly those involving VEGF inhibitors.
Collaborations
Julia has collaborated with notable colleagues in her field, including Federico Innocenti and Kouros Owzar. These partnerships have enhanced her research and contributed to the development of her patented methods.
Conclusion
Julia Quintanilha's innovative work in identifying risks associated with VEGF pathway inhibitors showcases her dedication to improving patient outcomes in cancer treatment. Her contributions to vascular health are significant and continue to influence the field.